Physician profile
Beth E Anlas
NPI 1871723700
$3,252.62
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $1,240 · 2021: $1,565 · 2022: $191.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $338.51 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $305.31 | 2021-2022 | |
| Gilead Sciences, INC. | $292.96 | 2019-2021 | |
| Amgen INC. | $274.31 | 2019-2021 | |
| Pfizer INC. | $207.33 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $167.64 | 2019-2021 | |
| Amarin Pharma, INC. | $152.76 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $124.63 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $101.31 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.56 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $98.02 | 2020-2022 | |
| Novo Nordisk INC | $97.17 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $96.17 | 2020-2021 | |
| Eisai INC. | $94.42 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.40 | 2020-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $89.22 | 2020-2021 | |
| Bausch Health US, LLC | $67.56 | 2021 | |
| Theratechnologies INC. | $58.66 | 2020-2021 | |
| Almatica Pharma LLC | $57.99 | 2021-2022 | |
| Viiv Healthcare Company | $48.39 | 2021-2022 | |
| Abbott Laboratories | $46.71 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.51 | 2021 | |
| Esperion Therapeutics, INC. | $37.89 | 2020-2021 | |
| Genentech USA, INC. | $32.23 | 2020-2021 | |
| Clarus Therapeutics INC. | $30.43 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.59 | 2020 | |
| Abbvie INC. | $22.90 | 2021 | |
| Astellas Pharma US INC | $22.74 | 2020 | |
| Upsher-Smith Laboratories LLC | $20.62 | 2021 | |
| Ibsa Pharma INC. | $17.66 | 2020 | |
| Amneal Pharmaceuticals LLC | $17.35 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.19 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.40 | 2020 | |
| Medtronic, INC. | $15.16 | 2021 | |
| Horizon Therapeutics Plc | $14.30 | 2020 | |
| Allergan, INC. | $13.62 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Anlas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.